BNP PARIBAS FINANCIAL MARKETS - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$342,947
+68.3%
81,267
+23.7%
0.00%
Q2 2023$203,729
+19.6%
65,719
-46.4%
0.00%
Q1 2023$170,406
+6.3%
122,594
+52.2%
0.00%
Q4 2022$160,277
-99.9%
80,541
-7.6%
0.00%
Q3 2022$176,021,000
-49.5%
87,139
-20.4%
0.00%
-100.0%
Q2 2022$348,267,000
-38.6%
109,518
-19.5%
0.00%0.0%
Q1 2022$567,162,000
-29.4%
136,010
-18.9%
0.00%0.0%
Q4 2021$802,924,000
+143.7%
167,625
+171.7%
0.00%
Q3 2021$329,478,000
+74.2%
61,700
+67.0%
0.00%
Q2 2021$189,153,000
-38.9%
36,944
-19.7%
0.00%
Q1 2021$309,439,000
+31.1%
45,979
-11.0%
0.00%
Q4 2020$235,990,000
+13.0%
51,639
-4.1%
0.00%
Q3 2020$208,837,000
-80.2%
53,824
-75.6%
0.00%
-100.0%
Q2 2020$1,052,160,000
+338.6%
221,042
+220.6%
0.00%
Q1 2020$239,908,000
+2.5%
68,939
+42.0%
0.00%
Q4 2019$234,025,000
+60.6%
48,553
-3.4%
0.00%
Q3 2019$145,696,000
+61.9%
50,240
+300.2%
0.00%
Q2 2019$90,012,000
-68.9%
12,554
-38.5%
0.00%
-100.0%
Q1 2019$289,451,000
+804.6%
20,427
+763.7%
0.00%
Q4 2018$31,998,000
-73.0%
2,365
-55.7%
0.00%
Q3 2018$118,561,000
+51.9%
5,343
+12.3%
0.00%
Q2 2018$78,062,0004,7570.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders